248 related articles for article (PubMed ID: 19444935)
1. Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast.
Miki Y; Suzuki T; Sasano H
J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):68-71. PubMed ID: 19444935
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H
Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280
[TBL] [Abstract][Full Text] [Related]
3. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
4. Intracrinology of estrogens and androgens in breast carcinoma.
Sasano H; Suzuki T; Miki Y; Moriya T
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):181-5. PubMed ID: 17933521
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
Takagi M; Miki Y; Miyashita M; Hata S; Yoda T; Hirakawa H; Sagara Y; Rai Y; Ohi Y; Tamaki K; Ishida T; Suzuki T; Ouchi N; Sasano H
Breast Cancer Res Treat; 2016 Feb; 156(1):45-55. PubMed ID: 26943913
[TBL] [Abstract][Full Text] [Related]
6. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
7. In situ production of estrogens in human breast carcinoma.
Suzuki T; Moriya T; Ishida T; Kimura M; Ohuchi N; Sasano H
Breast Cancer; 2002; 9(4):296-302. PubMed ID: 12459709
[TBL] [Abstract][Full Text] [Related]
8. Intracrine mechanism of estrogen synthesis in breast cancer.
Suzuki T; Moriya T; Ishida T; Ohuchi N; Sasano H
Biomed Pharmacother; 2003 Dec; 57(10):460-2. PubMed ID: 14637389
[TBL] [Abstract][Full Text] [Related]
9. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of estrogen-producing and metabolizing enzymes in benign breast disease: comparison with normal breast and breast carcinoma.
Sasaki Y; Miki Y; Hirakawa H; Onodera Y; Takagi K; Akahira J; Honma S; Ishida T; Watanabe M; Sasano H; Suzuki T
Cancer Sci; 2010 Oct; 101(10):2286-92. PubMed ID: 20682005
[TBL] [Abstract][Full Text] [Related]
11. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
12. Aromatase and in situ estrogen production in DCIS (ductal carcinoma in situ) of human breast.
Sasano H; Miki Y; Shibuya R; Suzuki T
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):242-5. PubMed ID: 19782135
[TBL] [Abstract][Full Text] [Related]
13. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast.
Yoda T; McNamara KM; Miki Y; Takagi M; Rai Y; Ohi Y; Sagara Y; Tamaki K; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
Cancer Sci; 2014 Nov; 105(11):1503-9. PubMed ID: 25230018
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
Hilborn E; Stål O; Jansson A
Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
[TBL] [Abstract][Full Text] [Related]
16. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions.
Suzuki T; Darnel AD; Akahira JI; Ariga N; Ogawa S; Kaneko C; Takeyama J; Moriya T; Sasano H
J Clin Endocrinol Metab; 2001 May; 86(5):2250-7. PubMed ID: 11344235
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.
Takagi K; Moriya T; Kurosumi M; Oka K; Miki Y; Ebata A; Toshima T; Tsunekawa S; Takei H; Hirakawa H; Ishida T; Hayashi S; Kurebayashi J; Sasano H; Suzuki T
Horm Cancer; 2013 Feb; 4(1):1-11. PubMed ID: 23096432
[TBL] [Abstract][Full Text] [Related]
18. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.
Suzuki T; Miki Y; Moriya T; Akahira J; Ishida T; Hirakawa H; Yamaguchi Y; Hayashi S; Sasano H
Int J Cancer; 2007 Jan; 120(2):285-91. PubMed ID: 17066438
[TBL] [Abstract][Full Text] [Related]
19. Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors.
Sato R; Suzuki T; Katayose Y; Miura K; Shiiba K; Tateno H; Miki Y; Akahira J; Kamogawa Y; Nagasaki S; Yamamoto K; Ii T; Egawa S; Evans DB; Unno M; Sasano H
Cancer Res; 2009 Feb; 69(3):914-22. PubMed ID: 19141651
[TBL] [Abstract][Full Text] [Related]
20. Estrogen inhibits cell proliferation through in situ production in human thymoma.
Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
